Ongoing funded Extramural/Intramural projects P

• Peripheral Blood Smear Investigator (PeBSI): an AI-assisted Solution for the Differential Diagnosis of Peripheral Blood Smear; Dr. Ritu Gupta
• Utility of DDPCR as novel method to detect CT-DNA in Head & Neck Cancer; Dr. Pranay Tanwar
• To establish Cryopreservation system for Multiple Myeloma (MM) cells; Dr. Ritu Gupta
• To determine the incidence and prevalence of second primary malignancies (SPMs) both preceding or following CLL diagnosis and their impact on the disease course and overall survival (OS); Dr. Ritu Gupta
• Targeting the tumor Microenvironment for novel therapeutic approaches in Multiple Myeloma (MM); Dr. Ritu Gupta
• Study of expression, function, and clinical significance of DNA damage repair pathway genes in acute lymphoblastic leukemia; Dr. Anita Chopra
• Understanding the role of RhoBTB2 in acute myeloid leukemia; Dr. Anita Chopra
• Identification of Novel markers for monitoring of Minimal residual disease in Acute Myeloid Leukemia by Multiparametric flowcytometry; Dr. G. Smeeta
• Identification of neoantigens for T cell therapy for Chronic Lymphocytic Leukemia (CLL); Dr. Gurvinder Kaur
• Identification and characterisation of plasma-derived cell free nucleic acid-based markers for early detection and monitoring of relapse in AML; Dr. Deepshi Thakral
• Centre for Advanced Research & Excellence in Leukemic Stem Cells (LSC) for Prognosis and Treatment (CARE-LSCPT) in Acute Myeloid Leukemia; Dr. Ritu Gupta
• Characterizing the functional role of DNA binding domain lacking novel alternative splice form of TET1 in acute myeloid leukemia, leukemic stem cells and can it be chemically targeted; Dr. Ritu Gupta
• Role of T cell activation and Follicular helper T cells in Multiple Myeloma; Dr. Ritu Gupta
• Study of prevalence and profile of predictive and prognostic molecular genetic aberrations in BCR-ABL1 negative B-cell acute lymphoblastic leukemia (B-ALL): A step towards personalized medicine; Dr. Sanjeev Kumar Gupta
• Cellular functions and clinical significance of NRf2 signaling T-ALL; Dr. Anita Chopra
• DBT-Wellcome trust intermediate career fellowship; Dr. Anita Chopra
• A prospective study to elucidate genetics, clinical and molecular factors in gall bladder carcinoma in Indian patients; Dr. Pranay Tanwar